Orthopedics This Week-logo

Orthopedics This Week

Medical >

We are the publishers of Orthopedics This Week, the most widely read publication in the Orthopedics industry. Orthopedics is, in our way of thinking, a small town with roughly 250,000 residents. These residents include clinicians, nurses, administrators, staff, suppliers, manufacturers, scientists, sales people, regulators, investors and consultants. So we think of ourselves as the community paper. We hope that our little paper, which we publish 40 times a year, will illuminate, elevate and educate you. Like small town publishers and writers everywhere, we are also part of this community and, for good or ill, that fact finds its way into our attitudes and commentaries. Yes, we are biased—in favor of you, our community. Roughly 3.3 times each month, Orthopedics This Week brings you the latest breaking orthopedic news. We also host innovative technology conferences and publish quarterly Market Forecasts and Analysis. Occasionally we also publish data and conference books. We are part of a unique, essential and endlessly fascinating industry. What a great place to be!

We are the publishers of Orthopedics This Week, the most widely read publication in the Orthopedics industry. Orthopedics is, in our way of thinking, a small town with roughly 250,000 residents. These residents include clinicians, nurses, administrators, staff, suppliers, manufacturers, scientists, sales people, regulators, investors and consultants. So we think of ourselves as the community paper. We hope that our little paper, which we publish 40 times a year, will illuminate, elevate and educate you. Like small town publishers and writers everywhere, we are also part of this community and, for good or ill, that fact finds its way into our attitudes and commentaries. Yes, we are biased—in favor of you, our community. Roughly 3.3 times each month, Orthopedics This Week brings you the latest breaking orthopedic news. We also host innovative technology conferences and publish quarterly Market Forecasts and Analysis. Occasionally we also publish data and conference books. We are part of a unique, essential and endlessly fascinating industry. What a great place to be!
More Information

Location:

United States

Description:

We are the publishers of Orthopedics This Week, the most widely read publication in the Orthopedics industry. Orthopedics is, in our way of thinking, a small town with roughly 250,000 residents. These residents include clinicians, nurses, administrators, staff, suppliers, manufacturers, scientists, sales people, regulators, investors and consultants. So we think of ourselves as the community paper. We hope that our little paper, which we publish 40 times a year, will illuminate, elevate and educate you. Like small town publishers and writers everywhere, we are also part of this community and, for good or ill, that fact finds its way into our attitudes and commentaries. Yes, we are biased—in favor of you, our community. Roughly 3.3 times each month, Orthopedics This Week brings you the latest breaking orthopedic news. We also host innovative technology conferences and publish quarterly Market Forecasts and Analysis. Occasionally we also publish data and conference books. We are part of a unique, essential and endlessly fascinating industry. What a great place to be!

Language:

English


Episodes

New Bill Streamlines Medical Device Process

7/5/2017
More
Bipartisan bill HR 2474 the Medical Product Review Harmonization Act of 2017 was submitted by California U.S. House of Representatives Mimi Walters and Ami Bera on May 16, 2017. If passed the bill will make certain Class II medical devices quicker and easier to get FDA clearance—including removing the need for redundant, duplicative review processes.

Duration:00:09:50

Hanging Tough: Lumbar Disc Replacement Over Fusion

7/5/2017
More
Jack Zigler keeps tracking his ProDisc patients, now 12 years post FDA approval. Just as he found at 3 years, 5 years and 7 years post approval, LADR is superior to fusion. And cheaper. Yet, on May 1, 2017 United Healthcare cited no long term data to label LADR “unproven.” Such a monumental mistake. Read on.

Duration:00:06:50

Spooks, Phishing and Cyberattacks Cripple Hospitals

5/30/2017
More
Spook technology stolen from U.S. spy agencies was used by hackers in a phishing cyberattack that crippled Britain’s National Health Service and computers worldwide. Outdated healthcare computer systems make healthcare systems easy targets. Read about this attack and see what you can do to keep patients safe.

Duration:00:11:10

Systemic Bias in Clinical Research

5/30/2017
More
Orthopedics This Week calls for a change in the economic framework for the clinical study process globally. The current system is undermined by systemic bias, lack of reproducibility and scalability. The causes come from multiple factors, many of which are non-corporate. It is time to address these issues.

Duration:00:13:12

The Last Men Standing

5/26/2017
More
Once upon a time lumbar arthroplasty was the most innovative and exciting development in spine surgery. Thirteen years ago the procedure hit a reimbursement wall. That was then, this is now. The resurrection of TOPS is the latest sign that lumbar arthroplasty has a second wind.

Duration:00:10:16

HCAHPS Report Card: A+ or C-?

5/11/2017
More
Millions of patients have evaluated their hospital, physician and nurse experience by way of the HCAHPS survey. Patients seem happy. But CMS isn’t. And poorer hospitals are calling foul. We checked with the expert about all this and read a handful of new studies. Conclusion: HCAHPS is a very good, albeit not perfect, thing.

Duration:00:10:09

All Aboard the Opioid Tax BOAT

5/11/2017
More
A bill is pending to amend the Internal Revenue Code’s Public Health Service Act (PHSA). The Budgeting for Opioid Addiction Treatment Act (BOAT) potentially places a one penny per milligram excise tax on most opioid prescriptions, with the revenue earmarked for opioid treatment programs.

Duration:00:07:18

A Cry for Help? FDA Bares Concerns in NEJM

5/11/2017
More
The most senior FDA executives went public with their worries, frustration even, we suspect, impotence regarding the plethora of stem cells therapies in the market last November. And that article, which appeared in the New England Journal of Medicine just keeps growing in influence. Here is what Celia Whitten, Peter Marks and Robert Califf said.

Duration:00:14:08

The Case of Brazil’s “Prosthetic Mafia”

4/13/2017
More
A private Brazilian insurance group claims U.S. orthopedic and other implant device makers and the U.S. government allegedly violated the Foreign Corruption Act. In numerous private lawsuits, the group alleges a “Prosthetic Mafia” gorged payers.

Duration:00:10:03

Galatz v. Crosby: Biceps Long Tendon: Pain Generator Requiring Tenodesis in TSA

4/13/2017
More
OK, everyone agrees tenodesis is the way to go for TSA. But with no prospective, randomized clinical trials regarding the long head of the biceps after total shoulder arthroplasty there remain too many questions. Which, of course, results in a spirited debate between Galatz and Crosby.

Duration:00:18:31

Flatow v Seitz: Optimal Glenoid Fixation Requires Cement

4/13/2017
More
Excellent debate this week. While both debaters agree that metal backed shoulder implants fail, the battle lines are clearly drawn when it comes to uncemented tantalum versus cemented poly. Evan Flatow and Bill Seitz give us an outstanding debate and review this week with Thomas Thornhill moderating.

Duration:00:19:28

The $1,000 Infection Tax

4/13/2017
More
In this new era of cost containment in medicine, adding over $1,000 to the cost of a procedure sounds fiscally irresponsible. A group of new studies about post op infection rates provide new insights into this critical issue as contributing commentator, Jay Mabrey, M.D., MBA, CPE explains.

Duration:00:05:25

New Evidence: Mild Concussions Related to ALS

4/13/2017
More
A new concussion model developed by Gretchen Thomsen, Ph.D., of the Regenerative Medicine Institute at Cedars-Sinai Medical Center in Los Angeles and colleagues triggered earlier onset of familial Amyotrophic Lateral Sclerosis symptoms. The researchers hope that the model can be used to develop novel therapies.

Duration:00:08:17

12 Leading North American Hand Surgeons

3/24/2017
More
According to their colleagues, these are the leading orthopedic hand surgeons in North America. Whether handling the wrist, elbow, or hand, these exemplary physicians have reached the pinnacle of their profession.

Duration:00:07:22

Romeo v Sperling: Moderate OA in Patients <50: Best Treated with Arthroscopic Debridement

2/23/2017
More
This is a very challenging problem. Young people with severe shoulder problems. Arthroplasty or arthroscopy? In this debate, the nuances are in full display. This is one of CCJR’s best. Congrats to Seth Greenwald for this excellent program.

Duration:00:18:51

Lewallen v. Hofmann: The Cemented All-Poly Tibia: An Affordable Care Act Solution

2/23/2017
More
All-poly tibia is a very cost effective alternative and, says David Lewallen, M.D., should be part of every knee surgeon’s armamentarium. BUT, newer modular designs and metal backed trays give today’s surgeon more versatility, counters Aaron Hofmann, M.D. This is an essential debate and a must read for every orthopod.

Duration:00:19:02

Pain Meds and Hearing Loss in Women; Houston Methodist’s New Biomechanics Lab; Implant Corrosion Update

2/23/2017
More
Familiar pain meds are associated with hearing loss in women! Houston Methodist is sporting a new ortho biomechanics lab, complete with state-of-the art motion equipment. And Rush is the only facility in the U.S. with a new technology to tackle implant corrosion.

Duration:00:10:11

Judge Backs DOJ Effort to Stop Aetna-Humana Merger

2/16/2017
More
Seven months after the DOJ filed a lawsuit to stop the $37B Aetna-Humana merger, along with a complementary Anthem-Cigna merger, a district judge rules in favor of the DOJ—but Aetna promises a quick appeal. What does a potential merger mean for the millions of Medicare Advantage customers who rely on these mega insurers for coverage?

Duration:00:10:21

Zimmer Biomet Finally Settles for $30.5 Million

2/16/2017
More
A decade-long legal battle between Zimmer Biomet, the Department of Justice (DOJ), and Securities and Exchange Commission (SEC) ended in a grand finale with a $30.5 million settlement. Allegations include violations of the U.S> Foreign Corrupt Practices Act (FCPA) and improprieties in Brazil and Mexico.

Duration:00:09:48

$31 Million Lawsuit: Orthopedic Surgeon Seeks Justice After Attack

1/26/2017
More
Renowned orthopedic surgeon Dr. Jamie Alexandra Dale is seeking justice and $31 million after she was attacked and left for dead by her ex-boyfriend and former NFL player Curtis Jordan. Her permanent injuries have left her unable to continue her surgery practice. Her story is not only heartbreaking but an indication of the economic toll this attack represented.

Duration:00:09:05